Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. It’s a new month, but it’s more of the same for the S & P 500. The broad index is on its way to another record…
We do not have enough money coming into this market. The funds flow only to stocks tied to the data center buildout and a few others. Even the most tangential of the data center “stories,” such as the warehouse REITs and machinery stocks like Cummins and Dover, manage to sustain themselves if they have healthy…
Time to buckle up. Earnings season is returning, and hopes of a durable resolution to the Iran war faced a setback over the weekend, injecting fresh uncertainty into the trading week ahead. Here’s a closer look at the three big things we are watching over the next five days. 1. Iran war: Peace talks between…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks gave up earlier gains and edged lower Friday afternoon , putting the S & P 500’s seven-day winning streak at risk. It’s been a strong…
CNBC’s Jim Cramer said Friday that the market’s become “incredibly overconfident” following the Iran-U.S. ceasefire news, which caused a massive rally in stocks this week. The S&P 500 closed Friday up 3.6% week to date. Gains were fueled by President Donald Trump‘s two-week pause on Iranian strikes, announced late Tuesday, which gave the market a…
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive,…
The Trump administration on Thursday imposed new tariffs on branded drugs from pharmaceutical companies that have not struck deals with the president to lower their U.S. drug prices – a long-awaited move that will likely only affect a small portion of drugmakers. “We need to make sure that our drug supply is protected, secure and…
The ripple effects of the war in Iran are ever-widening. Soaring oil prices continued to put pressure on stocks last week, with the Dow and Nasdaq slipping into correction territory, defined by declines of 10% or more from record highs. The Dow and Nasdaq sank 1.7% and nearly 2.2%, respectively, on Friday and just about…
Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat…
Dividend-paying companies are rapidly closing the earnings growth gap with technology stocks and contributing more earnings momentum to the S&P 500. After a significant increase over the past year on this key earnings metric, the trend suggests that dividend stocks may present an even stronger case to investors seeking income and safety in a volatile…
